JP2017528496A5 - - Google Patents

Download PDF

Info

Publication number
JP2017528496A5
JP2017528496A5 JP2017515948A JP2017515948A JP2017528496A5 JP 2017528496 A5 JP2017528496 A5 JP 2017528496A5 JP 2017515948 A JP2017515948 A JP 2017515948A JP 2017515948 A JP2017515948 A JP 2017515948A JP 2017528496 A5 JP2017528496 A5 JP 2017528496A5
Authority
JP
Japan
Prior art keywords
compound
hydrogen
fluorine
group
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017515948A
Other languages
English (en)
Japanese (ja)
Other versions
JP6517925B2 (ja
JP2017528496A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/071656 external-priority patent/WO2016046164A1/de
Publication of JP2017528496A publication Critical patent/JP2017528496A/ja
Publication of JP2017528496A5 publication Critical patent/JP2017528496A5/ja
Application granted granted Critical
Publication of JP6517925B2 publication Critical patent/JP6517925B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017515948A 2014-09-24 2015-09-22 置換されたオキソピリジン誘導体 Expired - Fee Related JP6517925B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14186082 2014-09-24
EP14186082.5 2014-09-24
PCT/EP2015/071656 WO2016046164A1 (de) 2014-09-24 2015-09-22 Substituierte oxopyridin-derivate

Publications (3)

Publication Number Publication Date
JP2017528496A JP2017528496A (ja) 2017-09-28
JP2017528496A5 true JP2017528496A5 (OSRAM) 2018-10-11
JP6517925B2 JP6517925B2 (ja) 2019-05-22

Family

ID=51589181

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017515948A Expired - Fee Related JP6517925B2 (ja) 2014-09-24 2015-09-22 置換されたオキソピリジン誘導体

Country Status (7)

Country Link
US (1) US20170298052A1 (OSRAM)
EP (1) EP3197873B1 (OSRAM)
JP (1) JP6517925B2 (OSRAM)
CN (1) CN106687458B (OSRAM)
CA (1) CA2961981A1 (OSRAM)
ES (1) ES2713624T3 (OSRAM)
WO (1) WO2016046164A1 (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3197896B1 (de) * 2014-09-24 2019-01-30 Bayer Pharma Aktiengesellschaft Substituierte oxopyridin-derivate
CA2979937A1 (en) * 2015-03-19 2016-09-22 Bayer Pharma Aktiengesellschaft Oxo-pyridine-derivatives as factor xia inhibitors for the treatment of thrombosis
JO3703B1 (ar) 2015-07-09 2021-01-31 Bayer Pharma AG مشتقات أوكسوبيريدين مستبدلة
JP2021514944A (ja) * 2018-02-27 2021-06-17 ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co.,Ltd. オキソピコリナミド誘導体の結晶形及びそれらの製造方法
PE20210165A1 (es) 2018-04-10 2021-01-26 Bayer Pharma AG Un derivado de oxopiridina sustituido
WO2020127508A1 (en) 2018-12-21 2020-06-25 Bayer Aktiengesellschaft Substituted oxopyridine derivatives
CN113474348A (zh) 2018-12-21 2021-10-01 拜耳公司 取代的氧代吡啶衍生物
CN112022848B (zh) * 2020-08-13 2022-02-22 中南大学湘雅二医院 索拉非尼在治疗1型糖尿病中的应用
CN115947680B (zh) * 2021-10-09 2025-09-23 山东新时代药业有限公司 一种替罗非班中间体化合物及其制备方法
CN116262740A (zh) * 2022-11-18 2023-06-16 成都施贝康生物医药科技有限公司 新型氧代吡啶类化合物及其制备方法和用途
CN116751136B (zh) * 2023-06-21 2025-08-29 成都施贝康生物医药科技有限公司 氧代吡啶类化合物的新型制备方法及关键中间体
CN116535392B (zh) * 2023-06-26 2023-09-05 成都施贝康生物医药科技有限公司 一种氧代吡啶类化合物的制备方法及中间体和应用
CN116874387B (zh) * 2023-06-21 2025-08-26 成都施贝康生物医药科技有限公司 氧代吡啶类化合物的新型制备方法及关键中间体
CN116730861A (zh) * 2023-06-21 2023-09-12 成都施贝康生物医药科技有限公司 氧代吡啶类化合物的新型制备方法及关键中间体
CN117164566B (zh) * 2023-09-07 2025-06-06 成都施贝康生物医药科技有限公司 一种氧代哒嗪类化合物及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EP2016072B1 (en) * 2006-05-05 2014-07-16 Millennium Pharmaceuticals, Inc. Factor xa inhibitors
JP5419706B2 (ja) * 2006-12-20 2014-02-19 タケダ カリフォルニア インコーポレイテッド グルコキナーゼアクチベーター
GB2497806A (en) * 2011-12-21 2013-06-26 Ono Pharmaceutical Co Pyridinone and pyrimidinone derivatives as factor XIa inhibitors
JP6137193B2 (ja) * 2011-12-21 2017-05-31 小野薬品工業株式会社 第XIa因子阻害剤としての新規ピリジノンおよびピリミジノン誘導体

Similar Documents

Publication Publication Date Title
JP2017528496A5 (OSRAM)
JP2016535031A5 (OSRAM)
JP2016515562A5 (OSRAM)
JP2016525136A5 (OSRAM)
JP2016535732A5 (OSRAM)
JP2018519323A5 (OSRAM)
PH12015502249A1 (en) Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
JP7034935B2 (ja) ピロロ[1,2-a]ピリミジニルカルボキサミド化合物および医学的障害の処置におけるその使用
JP2013542261A5 (OSRAM)
CN105636951A (zh) 酰胺类衍生物及其可药用盐、其制备方法及其在医药上的应用
RU2009136445A (ru) Способ получения высокочистого празугрель гидрохлорида
JP2014114295A5 (OSRAM)
JP2014509316A5 (OSRAM)
JP2012041365A5 (OSRAM)
JP2018516883A5 (OSRAM)
JP2016539092A5 (OSRAM)
JP2012532112A5 (OSRAM)
JP2018509426A5 (OSRAM)
JP2014521625A5 (OSRAM)
JP2009510044A5 (OSRAM)
JP2015514061A5 (OSRAM)
JP2016503785A5 (OSRAM)
RU2015155585A (ru) 4-алкинилимидазольное производное и лекарственное средство, включающее такое производное в качестве активного ингредиента
RU2018106948A (ru) Способ получения замещенных производных 3-(2-анилино-1-циклогексил -1н-бензимидазол-5-ил)пропановой кислоты
JP2014503001A5 (OSRAM)